Post
Amplia reports AMP945 data in preclinical model of pancreatic cancer
Amplia Therapeutics has reported data demonstrating the efficacy of AMP945 in a preclinical model of pancreatic cancer when used along …
Abbisko reports updated results from TGCT Phase Ib study
Abbisko Therapeutics has reported updated results from a Phase Ib study of Pimicotinib (ABSK021) for the treatment of advanced tenosynovial …
AstraZeneca reports positive results from endometrial cancer therapy trial
AstraZeneca has reported positive high-level results from the DUO-E trial (GOG 3041/ENGOT-EN10) of Imfinzi (durvalumab) and platinum-based chemotherapy combination followed …
Harbour reports results from HCC combo therapy trial
Harbour BioMed has reported results from a Phase Ib clinical trial of porustobart (HBM4003) combined with toripalimab for the treatment …
I-Mab reports encouraging data from Phase Ib/II NSCLC combo therapy trial
I-Mab has reported encouraging data from the Phase Ib/II study evaluating uliledlimab combined with toripalimab (TUOYI) in patients with treatment-naïve …
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
eFFECTOR reports interim data updates from cancer combo expansion cohort
eFFECTOR Therapeutics has reported positive interim data updates from a Phase II expansion cohort of zotatifin along with fulvestrant and …
Zentalis reports positive data from Phase Ib trial of cancer combo therapy
Zentalis Pharmaceuticals has reported positive data from a Phase Ib trial evaluating its WEE1 inhibitor, azenosertib combined with chemotherapy in …
FDA greenlights Neuralink for human trials
The US Food and Drug Administration (FDA) has approved Neuralink for its first in-human study. In a Twitter announcement, the …
Pfizer’s etrasimod aims to differentiate UC market with strong safety profile
The market for ulcerative colitis (UC) is filled with various treatment options, and the pipeline is relatively strong. The variety …
Xilio reports preliminary data from Phase I solid tumours therapy trial
Xilio Therapeutics has reported preliminary data from its Phase I clinical trial of XTX101 for the treatment of advanced solid …
Oncolytics gears up for Phase III trial in HR+/HER2- breast cancer
Oncolytics Biotech is getting ready for a registrational Phase III clinical trial after announcing positive results from a Phase II …
Topas launches Phase IIa trial of celiac disease therapy
Topas Therapeutics has launched a Phase IIa clinical trial of TPM502 to treat patients with celiac disease, an autoimmune disorder. The …
Stallergenes Greer initiates Phase III study of Staloral Birch
Stallergenes Greer has initiated a Phase III clinical study of Staloral Birch to treat children and adolescents with birch pollen-induced …
BIAL R&D doses first patient in ACTIVATE study of BIA 28-6156
BIAL R&D has dosed the first patient in its Phase II ACTIVATE study of BIA 28-6156 to treat patients with …
Transgene and BioInvent report positive data for oncolytic virus
BioInvent International and Transgene’s partnership is looking optimistic following positive Phase 1a data on its oncolytic virus BT-001 for the …